Bone Formation in Grafts with Bio-Oss and Autogenous Bone at Different Proportions in Rabbit Calvaria

Prior research has shown that bone graft materials influence dimensional stability and healing outcomes in craniofacial surgery. Established knowledge includes the role of autogenous bone in osteoconduction and osteoinduction. However, the specific interaction between Bio-Oss and autogenous bone remains unclear. No prior work had resolved how varying proportions of these materials affect bone formation. This gap motivated an investigation into volumetric stability and new bone formation. The proposed experimental model aimed to test graft composition effects in a controlled setting. Clinical and histological metrics were selected to evaluate outcomes. The study sought to clarify whether Bio-Oss alone or in combination with autogenous bone improves dimensional stability.

The study aimed to compare volumetric stability and bone formation in grafts with Bio-Oss and autogenous bone at different proportions. The specific problem addressed was the lack of evidence on optimal graft composition for bone regeneration. The motivation stemmed from the need to improve dimensional stability in bone grafting procedures. The experimental model used rabbit calvaria for standardized testing. Four titanium cylinders were implanted to simulate graft conditions. Groups were defined based on Bio-Oss and autogenous bone ratios. Clinical and histological outcomes were selected as primary endpoints. The study aimed to determine whether Bio-Oss enhances graft stability when combined with autogenous bone.

Ten rabbits received four titanium cylinders implanted in their calvaria. The animals were divided into four groups based on graft composition. Group I used Bio-Oss alone at 100%. Group II combined Bio-Oss (75%) with autogenous bone (25%). Group III used equal parts of Bio-Oss and autogenous bone. Group IV used autogenous bone alone at 100%. After twelve weeks, the rabbits were euthanized for sample collection. Clinical analysis measured dimensional stability using volumetric metrics. Histological analysis evaluated bone formation and biomaterial integration. The study design ensured randomization and controlled graft conditions.

Clinical analysis revealed superior dimensional stability in Groups I and II compared to Group IV. Group I showed a mean stability of 90.43 ± 8.99. Group II showed 90.87 ± 7.43, while Group IV had significantly lower stability. Histologically, Groups I, II, and III showed bone formation with biomaterial particles remaining. No significant differences were found in newly formed bone area across groups. Bio-Oss alone or in 75% proportion showed better stability than autogenous bone alone. The 25% autogenous bone addition did not compromise bone formation. The results suggest Bio-Oss contributes to dimensional stability regardless of autogenous bone proportion. The findings highlight the importance of graft composition in clinical outcomes.

The authors concluded that Bio-Oss alone or in 75% proportion with autogenous bone improves dimensional stability compared to autogenous bone alone. The results suggest that Bio-Oss enhances volumetric stability in the experimental model. No significant differences were observed in newly formed bone area across groups. The findings do not support the necessity of autogenous bone for bone formation. The study highlights the role of Bio-Oss in maintaining graft dimensions. The results may suggest that Bio-Oss acts as a stabilizing agent in bone grafting. The authors propose that graft composition influences clinical outcomes. The study provides evidence for the use of Bio-Oss in combination with autogenous bone.